We are live on
!
Find out more
CIP
Convergence Investment Partners Portfolio holdings
AUM
$611M
1-Year Est. Return
61.48%
This Fund
S&P 500
This Quarter
Est. Return
+8.47%
1 Year Est. Return
+61.48%
3 Year Est. Return
+199.5%
5 Year Est. Return
+275.62%
10 Year Est. Return
+998.75%
AUM
$678M
AUM Growth
-$48.9M
(-6.7%)
Cap. Flow
-$82.3M
Cap. Flow
% of AUM
-12.14%
Top 10 Holdings %
Top 10 Hldgs %
12.63%
Holding
435
New
127
Increased
76
Reduced
120
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$6.36M |
| 2 |
AT&T
T
|
+$6.07M |
| 3 |
CATM
Cardtronics plc Class A Ordinary Shares (UK)
CATM
|
+$5.04M |
| 4 |
CVG
Convergys
CVG
|
+$4.73M |
| 5 |
GXP
Great Plains Energy Incorporated
GXP
|
+$4.55M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Leidos
LDOS
|
+$5.48M |
| 2 |
RAX
Rackspace Hosting Inc
RAX
|
+$5.32M |
| 3 |
DYN
Dynegy, Inc.
DYN
|
+$5.03M |
| 4 |
Gilead Sciences
GILD
|
+$4.77M |
| 5 |
Verizon
VZ
|
+$4.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.1% |
| 2 | Technology | 13.84% |
| 3 | Industrials | 12.51% |
| 4 | Healthcare | 11.57% |
| 5 | Consumer Discretionary | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
AT&T
T
$165B
| $11.5M | 1.7% |
374,861
+192,126
| +105% | +$6.07M |
|
|
2
Pfizer
PFE
$140B
| $10.6M | 1.56% |
328,622
+190,239
| +137% | +$6.36M |
|
3
Apple
AAPL
$4.89T
| $10.3M | 1.53% |
365,644
-111,840
| -23% | -$2.96M |
|
4
JPMorgan Chase
JPM
$939B
| $9.85M | 1.45% |
147,985
-53,282
| -26% | -$3.47M |
|
5
Boeing
BA
$165B
| $8.13M | 1.2% |
61,674
-9,495
| -13% | -$1.25M |
|
6
Walmart Inc
WMT
$871B
| $7.98M | 1.18% |
331,971
+21,309
| +7% | +$517K |
|
7
Intel
INTC
$464B
| $7.12M | 1.05% |
188,627
-70,191
| -27% | -$2.49M |
|
8
Amgen
AMGN
$203B
| $7.08M | 1.05% |
42,469
+469
| +1% | +$79.3K |
|
9
Microsoft
MSFT
$2.84T
| $6.55M | 0.97% |
113,698
-17,786
| -14% | -$1M |
|
10
GE Aerospace
GE
$367B
| $6.51M | 0.96% |
45,871
-13,226
| -22% | -$1.97M |
|
11
Qualcomm
QCOM
$176B
| $6.3M | 0.93% |
91,935
+65,832
| +252% | +$4M |
|
12
Chevron
CVX
$388B
| $6.03M | 0.89% |
58,566
-917
| -2% | -$93.6K |
|
13
AbbVie
ABBV
$458B
| $5.95M | 0.88% |
94,353
-17,523
| -16% | -$1.13M |
|
|
FITB
14
Fifth Third Bancorp
FITB
$52B
| $5.64M | 0.83% |
275,656
+129,210
| +88% | +$2.49M |
|
|
DF
15
DELISTED
Dean Foods Company
DF
| $5.36M | 0.79% |
327,025
-57,124
| -15% | -$998K |
|
16
Merck
MRK
$324B
| $5.21M | 0.77% |
87,572
+8,660
| +11% | +$506K |
|
17
Procter & Gamble
PG
$343B
| $5.17M | 0.76% |
57,568
-12,286
| -18% | -$1.07M |
|
|
CATM
18
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $5.11M | 0.75% |
+114,485
| New | +$5.04M |
|
|
CVG
19
DELISTED
Convergys
CVG
| $5.08M | 0.75% |
+166,857
| New | +$4.73M |
|
20
Valero Energy
VLO
$89.8B
| $4.99M | 0.74% |
94,233
-18,898
| -17% | -$1.01M |
|
21
Warner Bros
WBD
$64.6B
| $4.96M | 0.73% |
184,404
+120,842
| +190% | +$3.1M |
|
22
Teradata
TDC
$2.68B
| $4.93M | 0.73% |
159,207
+107,782
| +210% | +$3.21M |
|
|
NUAN
23
DELISTED
Nuance Communications, Inc.
NUAN
| $4.9M | 0.72% |
390,589
+96,293
| +33% | +$1.26M |
|
|
24
Verizon
VZ
$194B
| $4.88M | 0.72% |
93,798
-88,714
| -49% | -$4.76M |
|
25
Altria Group
MO
$122B
| $4.79M | 0.71% |
75,670
+1,233
| +2% | +$81.9K |
|
Similar funds
FFWA
VV
CBB
1SAMC
PM
PL
BFC
DCM
Convergence Investment Partners's Q3 2016 Portfolio in Review
As of Q3 2016, Convergence Investment Partners held 435 positions worth $678M, down 6.7% from $727M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Convergence Investment Partners withdrew a net $82.3M in Q3 2016, closing 111 positions and reducing 120 holdings. Its most notable exit was Leidos, an estimated $5.48M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Industrials.
Against the trend, Convergence Investment Partners opened a new position in Cardtronics plc Class A Ordinary Shares (UK) worth $5.11M.
- Convergence Investment Partners's largest Q3 2016 buy was Cardtronics plc Class A Ordinary Shares (UK): 114,485 shares worth $5.11M.
- Convergence Investment Partners added most to Pfizer in Q3 2016, an estimated $6.36M increase.
- Convergence Investment Partners's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $4.77M.
- Convergence Investment Partners fully exited Leidos in Q3 2016, selling an estimated $5.48M.
- Convergence Investment Partners's ten largest holdings make up 13% of its $678M portfolio in Q3 2016.
- Convergence Investment Partners opened 127 new positions and closed 111 in Q3 2016.
- Convergence Investment Partners's portfolio value fell 6.7% quarter-over-quarter to $678M.
Based on Convergence Investment Partners's 13F filing for Q3 2016, filed 10 Nov 2016.